Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Caicun Zhou
Person

Caicun Zhou

Tracked across 1 events · 14 articles · First seen May 30, 2026 · Last active May 31, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 0
Tech
Kelun-Biotech sac-TMT Phase III Results
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced positive results from its Phase III OptiTROP-Lung05 clinical study for sacituzumab tirumotecan (sac-TMT) in combination with pembrolizumab (KEYTRUDA) as a first-line treatment for non-small cell lung cancer (NSCLC). The…
Impact: Professor Caicun Zhou presented the positive results of the OptiTROP-Lung05 study, highlighting its potential to bring new treatment options for lung cancer patients.
May 30, 2026 · 14 articles
NEWSDESK
Track Caicun Zhou live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.